94 related articles for article (PubMed ID: 2488545)
1. Purification of the migration stimulating factor produced by fetal and breast cancer patient fibroblasts.
Grey AM; Schor AM; Rushton G; Ellis I; Schor SL
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2438-42. PubMed ID: 2488545
[TBL] [Abstract][Full Text] [Related]
2. Potentiality, Limitations, and Consequences of Different Experimental Models to Improve Photodynamic Therapy for Cancer Treatment in Relation to Antiangiogenic Mechanism.
Majerník M; Jendželovský R; Fedoročko P
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751731
[TBL] [Abstract][Full Text] [Related]
3. Cancer-Associated Fibroblasts Enhance Survival and Progression of the Aggressive Pancreatic Tumor Via FGF-2 and CXCL8.
Awaji M; Futakuchi M; Heavican T; Iqbal J; Singh RK
Cancer Microenviron; 2019 Apr; 12(1):37-46. PubMed ID: 31025289
[TBL] [Abstract][Full Text] [Related]
4. Boswellia frereana suppresses HGF-mediated breast cancer cell invasion and migration through inhibition of c-Met signalling.
Parr C; Ali AY
J Transl Med; 2018 Oct; 16(1):281. PubMed ID: 30314527
[TBL] [Abstract][Full Text] [Related]
5. The role of the tumor microenvironment in regulating angiogenesis.
Watnick RS
Cold Spring Harb Perspect Med; 2012 Dec; 2(12):a006676. PubMed ID: 23209177
[TBL] [Abstract][Full Text] [Related]
6. Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth.
Carito V; Bonuccelli G; Martinez-Outschoorn UE; Whitaker-Menezes D; Caroleo MC; Cione E; Howell A; Pestell RG; Lisanti MP; Sotgia F
Cell Cycle; 2012 Sep; 11(18):3403-14. PubMed ID: 22918248
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.
Silletti S; Paku S; Raz A
Pathol Oncol Res; 1997 Sep; 3(3):230-54. PubMed ID: 18470736
[TBL] [Abstract][Full Text] [Related]
8. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration.
Tomkowicz B; Rybinski K; Foley B; Ebel W; Kline B; Routhier E; Sass P; Nicolaides NC; Grasso L; Zhou Y
Proc Natl Acad Sci U S A; 2007 Nov; 104(46):17965-70. PubMed ID: 17986615
[TBL] [Abstract][Full Text] [Related]
9. Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity.
Shekhar MP; Santner S; Carolin KA; Tait L
Am J Pathol; 2007 May; 170(5):1546-60. PubMed ID: 17456761
[TBL] [Abstract][Full Text] [Related]
10. Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress.
Sivridis E; Giatromanolaki A; Koukourakis MI
J Clin Pathol; 2005 Oct; 58(10):1033-8. PubMed ID: 16189147
[TBL] [Abstract][Full Text] [Related]
11. Models of breast cancer: is merging human and animal models the future?
Kim JB; O'Hare MJ; Stein R
Breast Cancer Res; 2004; 6(1):22-30. PubMed ID: 14680482
[TBL] [Abstract][Full Text] [Related]
12. Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast.
Shekhar MP; Pauley R; Heppner G
Breast Cancer Res; 2003; 5(3):130-5. PubMed ID: 12793893
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression.
Schor SL; Schor AM
Breast Cancer Res; 2001; 3(6):373-9. PubMed ID: 11737888
[TBL] [Abstract][Full Text] [Related]
14. NK4, a four-kringle antagonist of HGF, inhibits spreading and invasion of human pancreatic cancer cells.
Maehara N; Matsumoto K; Kuba K; Mizumoto K; Tanaka M; Nakamura T
Br J Cancer; 2001 Mar; 84(6):864-73. PubMed ID: 11259105
[TBL] [Abstract][Full Text] [Related]
15. Induction of c-met proto-oncogene expression at the metastatic site.
Imai J; Watanabe M; Sasaki M; Yamaguchi R; Tateyama S; Sugano S
Clin Exp Metastasis; 1999 Jul; 17(5):457-62. PubMed ID: 10651314
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts.
Matsumoto-Taniura N; Matsumoto K; Nakamura T
Br J Cancer; 1999 Sep; 81(2):194-202. PubMed ID: 10496342
[TBL] [Abstract][Full Text] [Related]
17. Stromal IGF-II messenger RNA in breast cancer: relationship with progesterone receptor expressed by malignant epithelial cells.
Giani C; Pinchera A; Rasmussen A; Fierabracci P; Bonacci R; Campini D; Bevilacqua G; Trock B; Lippman ME; Cullen KJ
J Endocrinol Invest; 1998 Mar; 21(3):160-5. PubMed ID: 9591211
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of motility stimulating factor secreted from pancreatic cancer cells: role in tumor invasion and metastasis.
Sakurai Y; Sawada T; Chung YS; Funae Y; Sowa M
Clin Exp Metastasis; 1997 May; 15(3):307-17. PubMed ID: 9174130
[TBL] [Abstract][Full Text] [Related]
19. Detection and characterization of an activity which aligns mesodermal cells into parallel arrays.
Li SF; Klajn E; Marotta R; Parish RW
J Muscle Res Cell Motil; 1997 Apr; 18(2):133-48. PubMed ID: 9127262
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
